henhaobio
Sign in

bioRxivMicrobiologyPreprint

Biofilm Formation by Pseudomonas aeruginosa in Medium Supplemented with Adult Bovine Serum and the Anti-Biofilm Activity of β-Lactam Antibiotics

Junichi Mitsuyama, Kyoko Asano, Yoshitomo MorinagaiD

PDFDOI

Abstract

Pseudomonas aeruginosa is a major opportunistic pathogen known for its ability to form biofilms in vivo, which contributes significantly to its resistance to antimicrobial treatment. In this study, we examined the biofilm-forming capacity of a clinical isolate cultured in medium supplemented with 30% adult bovine serum (ABS). Under these host-mimicking conditions, mature biofilms developed on microplate surfaces within 8 hours. Among the {beta}-lactam antibiotics evaluated, piperacillin and cefoperazone exhibited potent anti-biofilm activity at concentrations as low as 1/8,192 to 1/256 of their respective minimum inhibitory concentrations (MICs). In contrast, ceftazidime and meropenem required significantly higher concentrations (approximately 1/16 MIC) to produce similar effects. The anti-biofilm activity of piperacillin and cefoperazone was abolished when ABS was defatted with n-hexane or when magnesium sulfate was added to the medium, suggesting that a lipid-dependent membrane permeabilization mechanism may be involved. These findings highlight the utility of host-mimicking conditions in evaluating the activity of antibiotics against biofilms and suggest that certain {beta}-lactam agents may have previously unrecognized anti-biofilm effects mediated through serum-associated components.

Citations
0

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISBernardes '17Kumar '22Yaeger '23Orazi '19Manohar '18Heinonen '20
79% semantic matchMicrobiology
Erik van Tilburg Bernardes, Laetitia Charron-Mazenod, David Reading+2 more·Antimicrobial Agents and Chemotherapy·May 1, 2017